Open access
Oct 2026
Antiviral and inflammatory immune signatures in anti-CD20-treated multiple sclerosis: a cross-sectional study
CD20-targeting monoclonal antibodies are highly effective therapies for relapsing multiple sclerosis (MS). We examined how anti-CD20 therapy reshapes antiviral T-cell immunity, innate inflammatory tone, and blood markers of neuroaxonal injury. In this cross-sectional study, adults with relapsing MS were enrolled at two...
Silvia D'Orso, M. Picozza, G. Guerrera et al.
· Journal of Neurology · 0 citations